IPSC logo

IPSCCentury Therapeutics Inc

$2.27
$0.0252
(1.13%)
Pre-Market
Updated: 07:41 AM EDT·Prev Close $2.24
Reported EarningsMay 13
Mkt Cap$403.99M
Vol15.00
News
all
press releases
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company PR Newswire SAN FRANCISCO, June 2, 2026 Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)SAN FRANCISCO, June 2...
PR Newswire
News Placeholder
More News
News Placeholder
Wall Street Zen Upgrades Century Therapeutics (NASDAQ:IPSC) to Hold
Wall Street Zen raised Century Therapeutics from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Century Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat
News Placeholder
What is HC Wainwright's Estimate for IPSC Q1 Earnings?
Century Therapeutics, Inc. (NASDAQ:IPSC - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for shares of Century Therapeutics in a research note issued on...
MarketBeat
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Hold" by Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been given an average recommendation of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports...
MarketBeat
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 19.3% in March
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 10,289,543 shares, an increase of 19.3% from the March 15th total of 8,626,834 shares. Based on an average daily volume...
MarketBeat
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 13th, there was short interest totaling 8,626,834...
MarketBeat
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are currently covering the firm, Marketbeat...
MarketBeat
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...
MarketBeat
News Placeholder
Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) SVP Douglas Carr sold 7,043 shares of the company's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.